Clear Scientific’s CEO and General Counsel joins Eureka: A Dose of Science Podcast sponsored by Charles River Laboratories
- May 7
- 1 min read
Cambridge, MA | May 2026
Clear Scientific’s CEO, Shekar Shetty, and General Counsel, Winston Henderson, joins the May 5th podcast, episode 116 of Eureka: A Dose of Science, a multimedia platform that continually searches for creative ways to talk about science, including breaking news science and the people behind it.
“What if one shot could reverse a meth overdose? In this episode of Sounds of Science, we explore CS-1103—Clear Scientific's breakthrough therapy with FDA Fast Track status that works like Pac-Man to clear toxins fast. Could this change emergency medicine forever? Tune in to find out.”
About Clear Scientific:
Clear Scientific was co-founded in March 2019 by Professor George M. Whitesides of Harvard University with technology licensed from Massachusetts General Hospital and the University of Maryland.
Clear Scientific is pioneering a new paradigm for treatment of conditions and diseases that involve an excess of specific compounds in the body. The company is developing highly selective, small molecule sequestrants that bind, inactivate, and rapidly clear these excess compounds from the body. Clear Scientific receives funding from the National Institutes of Health (NIH) / National Institute on Drug Abuse (NIDA) and is working with their network of medical and academic professionals.
About CS-1103:
CS-1103 is a first-in-class injectable small molecule sequestrant that binds and inactivates target compounds, rapidly reversing their effects and accelerating their clearance into urine. The Company is initially targeting methamphetamine, fentanyl and cocaine overdose, representing close to 95% of the drug fatalities in the US. Clear Scientific’s pipeline includes indications in central nervous system (CNS), metabolic diseases, amongst others.
For more information, visit https://www.clearsci.com
Comments